Zimbabwe has turned down a major American health deal valued at $367m (£272m) over five years because of Washington's request for sensitive biological samples.
This move came to light following a official document from December was leaked, revealing that Head of State Emmerson Mnangagwa felt the deal was "unbalanced".
An official spokesperson later stated that the US was demanding access to biological samples for scientific study and profit while refused to guarantee the resulting advantages from any future treatments.
"We will now turn to the difficult and regrettable process of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had furnished more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A medical body in Zimbabwe has appealed for continued talks to find a agreement suitable to all parties so the nation's critical HIV programme can continue.
Wider Background
Zimbabwe's decision follows a comparable case in neighbouring Kenya, where a high court suspended a related deal with the US after legal challenges were raised about the safety of Kenyans' health data.
After returning to the presidency recently, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
USAID had managed assistance for the American government, but Trump claimed its expenditure was "wasteful" and his government was pursuing government-to-government agreements to enhance openness and accountability.
Based on reports, 16 nations in Africa have so far signed these new health pacts, representing over $18.3bn in committed funds.
Specifics of the Rejected Deal
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"It is our view this partnership would have delivered significant advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy via American-funded programmes," the Ambassador commented.
However, official spokesman Nick Mangwana said the arrangement was "unequal".
"Our nation was requested to share its biological resources and data over an extended period, without any equivalent guarantee of benefiting from any medical innovations – like new medicines or tests – that might be developed from that shared data," Mangwana explained.
"Put simply, our nation would provide the raw materials for scientific discovery with no assurance that the final treatments would be available to our population if a new health crisis emerge."
National Interest and Global Health
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were upending frameworks previously set up via the international health agency.
The spokesperson cited its Pandemic Benefit-Sharing framework created to manage future pandemics.
"This system is designed to ensure that when a nation provides its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to create them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," he added.
"We encourage further discussions with our American counterparts on how future co-operation might be arranged in a way that respects the sovereignty and interests of both nations."
Medical Community Response
A leading public health body expressed it recognised the government's concerns, but suggested that negotiations need to persist since a large portion of the country's HIV programmes were funded by external financing.
"If technical issues exist, such as those involving data governance or agreement terms, these can frequently be resolved through technical clarification and mutually agreed protections," the group commented.
The situation emphasises the continuing challenges between receiving much-needed international aid and safeguarding national sovereignty in an increasingly interconnected world.